Ovoca Bio Investor Relations Material

Ovoca Bio plc is a clinical-stage biopharmaceutical company focusing on women's health. The company is actively involved in developing novel therapeutic products, particularly targeting female sexual dysfunction. Its lead candidate, a treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women, is under clinical development. Ovoca Bio's research and development efforts are geared towards addressing unmet medical needs in this area. The company is headquartered in Dublin, Ireland, and its shares are listed on the Euronext Dublin.